1. Home
  2. UBXG vs IGC Comparison

UBXG vs IGC Comparison

Compare UBXG & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBXG
  • IGC
  • Stock Information
  • Founded
  • UBXG 2018
  • IGC 2005
  • Country
  • UBXG China
  • IGC United States
  • Employees
  • UBXG N/A
  • IGC N/A
  • Industry
  • UBXG
  • IGC Biotechnology: Pharmaceutical Preparations
  • Sector
  • UBXG
  • IGC Health Care
  • Exchange
  • UBXG Nasdaq
  • IGC Nasdaq
  • Market Cap
  • UBXG 38.2M
  • IGC 39.8M
  • IPO Year
  • UBXG 2024
  • IGC N/A
  • Fundamental
  • Price
  • UBXG N/A
  • IGC $0.42
  • Analyst Decision
  • UBXG
  • IGC Strong Buy
  • Analyst Count
  • UBXG 0
  • IGC 2
  • Target Price
  • UBXG N/A
  • IGC $4.00
  • AVG Volume (30 Days)
  • UBXG 734.4K
  • IGC 695.2K
  • Earning Date
  • UBXG 01-01-0001
  • IGC 11-11-2025
  • Dividend Yield
  • UBXG N/A
  • IGC N/A
  • EPS Growth
  • UBXG N/A
  • IGC N/A
  • EPS
  • UBXG N/A
  • IGC N/A
  • Revenue
  • UBXG $39,603,353.00
  • IGC $1,327,000.00
  • Revenue This Year
  • UBXG N/A
  • IGC $15.26
  • Revenue Next Year
  • UBXG N/A
  • IGC $3.41
  • P/E Ratio
  • UBXG N/A
  • IGC N/A
  • Revenue Growth
  • UBXG N/A
  • IGC 24.95
  • 52 Week Low
  • UBXG $1.62
  • IGC $0.25
  • 52 Week High
  • UBXG $9.92
  • IGC $0.50
  • Technical
  • Relative Strength Index (RSI)
  • UBXG 35.32
  • IGC 52.73
  • Support Level
  • UBXG $1.76
  • IGC $0.39
  • Resistance Level
  • UBXG $1.94
  • IGC $0.43
  • Average True Range (ATR)
  • UBXG 0.19
  • IGC 0.02
  • MACD
  • UBXG 0.02
  • IGC -0.00
  • Stochastic Oscillator
  • UBXG 27.42
  • IGC 44.42

About UBXG U-BX Technology Ltd. Ordinary Shares

U-BX Technology Ltd is focused on providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers. It helps institutional clients obtain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or its clients' promotion time through those channels. The company derives a majority of its revenue by providing digital promotion services to its clients and also engages in providing risk assessment services, and value-added bundled benefits. It has developed an algorithm named Magic Mirror, to calculate payout risks for insurance carriers to underwrite auto insurance coverage. Geographically, all of the company's revenue is derived from Mainland China.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Share on Social Networks: